Real-World Application of the Pediatric Glucocorticoid Toxicity Index in Children with Lupus Nephritis: A Feasibility and Initial Validation Study

Emily Zhang, Joyce C. Chang, Olha Halyabar(Boston Children's Hospital), Mindy S. Lo(Boston Children's Hospital), Liyoung Kim(Boston Children's Hospital), Melissa M. Hazen(Boston Children's Hospital), G. Alonzi(Boston Children's Hospital), Esra Meidan(Boston Children's Hospital), Ankana Daga, Madeline Hlobik(Boston Children's Hospital), Mary Beth F. Son(Boston Children's Hospital), Sarah Capponi(Children's Hospital of Philadelphia), Ahmad Bakhsh, Peter Nigrovic, Siobhan Case, Karen Costenbader, Lauren A. Henderson, Rebecca Scobell, Robert Sundel, Jonathan Samuel Hausmann, Daniel Ibanez(Boston Children's Hospital), Ezra M. Cohen(Boston Children's Hospital)
Unknown
January 1, 2023
10.13140/rg.2.2.36477.12006
Cited by 0

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
|Arthritis & Rheumatology|2020|415